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Introduction
The identification of genes that show changes in expression between varying biological conditions
is a common goal in microarray experiments [1]. Differential expression can be studied from a
static or temporal viewpoint. In a static experiment the arrays are obtained irrespective of time,
essentially taking a snapshot of gene expression. In a temporal experiment the arrays are collected
over a time course, allowing one to capture the dynamic behavior of gene expression. A large
amount of work has been done on the problem of identifying differentially expressed genes in
static experiments [2–15]. Since the regulation of gene expression is a dynamic process, it is also
important to identify and characterize changes in gene expression over time. Here we present a
general statistical method that identifies genes that are differentially expressed over time. We apply
the method to two recent studies that we have carried out on humans.
A number of clustering methods have been applied to time course microarray data, including
hierarchical clustering [16, 17], principal components based clustering [18], Bayesian model-based
clustering [19], and K-means clustering of curves [20, 21]. None of these clustering methods is
directly applicable to identifying genes that show statistically significant changes in expression
over time. The K-means clustering method has been modified to compare expression over time
between two groups [22], but this method can only be applied to a few hundred genes at a time
because of the computational cost of fitting a single model to all genes simultaneously [20,21]. This
approach also requires that the statistical significance be calculated under the assumption that the
clustering fit to one of the groups is true, which is nonstandard and potentially problematic. The
method that is proposed here draws on ideas from the extensive statistical literature on time course
data analysis [23, 24], particularly spline based methods [25–33]. It is applicable to both detecting
changes in expression over time within a single biological group, and to detecting differences in
the behavior of expression over time between two or more groups. Individuals may be sampled
at multiple time points, or each time point may represent an independently sampled individual.
The computational cost is not substantially greater than methods for static experiments, so there
is no impeding limit on the number of genes that may be tested. We apply the method here to
microarray studies that each measures about forty thousand genes.
A number of methods already exist [2, 3, 8–12] that are appropriate for identifying genes that
are differentially expressed between two or more static biological conditions. These methods are
designed to compare unordered categorical conditions, such as three different cancer tumor types
[34] or two different treatments [9]. Therefore, one could apply these to a time course study by
treating each time point as a different “biological condition”, even though the inherent ordering
and spacing provided by time points would be ignored. However, adapting these methods requires
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the study to be perfectly balanced, that is, each time point must have the same number and type
of observations. Also, they require that more than one observation be obtained at each time point;
otherwise, a “biological condition” would have only one observation, which renders the existing
methods useless. The method proposed here does not place either of these restrictions on the study
design, and it takes into account the ordering and spacing information provided by the time points.
It is even possible to conduct an analysis when every sample has been obtained at a unique time
point.
No existing method for static differential expression could be straightforwardly applied to the
studies we analyze here, even when treating the time points as categorical biological conditions. In
one study, a control individual is missing two time points, thereby yielding an unbalanced design.
One could try to impute these missing time points for every gene, but this would require a lot
of modeling assumptions and unnecessary work. Imputing missing time points is not necessary
in our proposed method. In the other study, there are many time points where only one array
has been obtained. This unavoidable feature is not a problem since our proposed method borrows
information across the time points by directly utilizing the time structure. However, one cannot
adapt currently available methods to this study unless the data are binned in an arbitrary way so
that a balanced experiment with repeated observations is fabricated.
As it turns out, when a balanced design exists with repeated observations at each time point,
then several existing approaches can be formulated a special case of our procedure. That is, if one
applies our method so that it uses every available degree of freedom, then the procedure is a type
of classical ANOVA similar to those proposed for microarrays [3, 10, 11], which is also similar to
modified versions of classical ANOVA such as SAM [9, 15]. However, if every degree of freedom is
used, then the time structure has essentially been ignored. As long as a model using less degrees
of freedom appropriately captures the signal across time, then standard statistical theory says that
this model will be more powerful. Therefore, our method is more powerful whenever it utilizes the
time structure thereby saving degrees of freedom. Since the proposed procedure can be viewed as a
generalization of the existing methods for static experiments, it should be noted that many of the
modifications to standard t-tests and F-tests that have been proposed (such as shrinking variance
estimates [9]) can be applied to our method as well. However, most of these modifications are not
yet completely justified or understood, so we defer such fine tuning.
The proposed method is applied to two recent studies that we have carried out on humans.
These studies encompass both types of sampling (longitudinal and independent, discussed in detail
below) and both types of differential expression over time (between groups and within a single
group). In one study, gene expression was monitored over time in controls and in individuals
treated with endotoxin, which is widely used to study acute inflammatory and immune response.
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Our goal is to understand the mechanism of endotoxin response by identifying genes with expression
that is different over time between the treated and untreated groups [35]. In a second study, we
examined the effect of age on gene expression in the kidney, where samples were obtained from
human subjects ranging in age from 27 to 92 years. Although genome-wide transcriptional changes
associated with age have been studied in several model organisms [36–38], age-dependent expression
in humans is unclear. The goal here was to identify genes whose expression changes significantly
with respect to age in human kidney cortex tissue [39]. Genes are identified in both studies that
corroborate previous findings and provide insights into these problems.
Materials and Methods
Sample preparations. Details on the protocols are described elsewhere [35, 39]. Endotoxin study: In
order to monitor gene expression responses to bacterial endotoxin in blood leukocytes, eight adult volunteers
were recruited by the Clinical Research Center at UMDNJ-Robert Wood Johnson Medical School. Four
subjects were administered endotoxin and four were administered a placebo. Blood samples were collected
before endotoxin infusion and at 2, 4, 6, 9, and 24 hours after infusion. The leukocytes were isolated
from the blood samples using a modified lysis protocol [35]. Total RNA was extracted using an RNeasy
kit (Qiagen, Inc). Samples from hours 4 and 6 were unavailable for one of the controls. Kidney aging
study: To investigate changes in gene expression in the human kidney across different ages, samples were
obtained from normal kidney tissues removed at nephrectomy for various medical reasons or renal transplant
biopsy from 74 patients ranging in age from 27 to 92 years, and dissected into cortex and medulla sections
based on histological evaluation. Each frozen tissue section was homogenized and total cellular RNA was
isolated according to the TRIzol Reagent protocol. Comprehensive evaluations were performed and reported
elsewhere on various medical factors of the patients [39], and it is unlikely that these factors have confounded
age-regulated changes in gene expression [39,40]. Only cortex samples (72 in total) were used in this study.
Microarray analysis. Total RNA was extracted, and messenger RNA amplified and hybridized onto Hu-
man U133A and U133B GeneChips according to the protocols recommended by Affymetrix (Santa Clara,
CA). 44,924 probe sets on the arrays were analyzed. Normalization was performed using dChip, and expres-
sion levels were calculated using the perfect match only model [41]. Expression values were then transformed
by taking log2(Data + 10) where the relatively negligible number 10 was added to stabilize the variance of
values close to zero.
Statistical and computational details. Exhaustive details (including formula derivations, algorithms
and statistical justifications) can be found in the Supplementary Information.
Functional analysis of significant genes. Probe sets on Affymetrix U133 GeneChips were mapped to
gene IDs (http://www.ncbi.nlm.nih.gov/entrez/, http://www.affymetrix.com/analysis/netaffx/).
Endotoxin study: Among the 4163 probe sets significant at 0.1%, 2914 unique genes were identified from
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3892 probe sets having mapped gene IDs (271 were unmapped). Kidney study: Among the 417 probe sets
significant at 10%, 300 unique genes were identified from 364 probe sets with mapped gene IDs and 53
unmapped. In both studies, the IngenuityTM Pathways Knowledge Base (IPKB) was used for functional
analysis of genes. Briefly, the IPKB consists of more than a million individually-modelled relationships
into an ontology of more than 550,000 biological concepts. Relationships between genes, proteins, small
molecules, complexes, cells, processes, and diseases were manually extracted by Ph.D.-level scientists from
over 200,000 peer-reviewed articles [35].
Removal of probe sets in the kidney aging study. The human subjects observed in the kidney
aging study did not represent a purely random sample. Because of this, any observed temporal differential
expression could be confounded with unobserved variables. An initial analysis showed that a number of
probe sets contained outliers possibly due to unobserved variables. (These probe sets will disproportionately
be called significant because they violate the statistical assumptions needed to perform a valid significance
analysis.) The outliers showed no systematic patterns with respect to probe sets or arrays (e.g., no particular
array was infested with outliers), although outliers tended to appear in clumps with respect to age within
a probe set. We attempted to alleviate this issue by selecting probe sets whose expression is well explained
by the available sex variable, irrespective of any age dependent behavior. We applied a filtering technique
that sought to identify these probe sets, while at the same time guarding against anti-conservatively biasing
the subsequent significance analysis. 35,068 such probe sets were identified when considering the clinical
variable identifying sex, reducing the total number of probe sets included in the analysis by 9856. Through
an extensive simulation study, we were able to show that the filtering method effectively removed probe
sets confounded by unobserved variables while not inflating the significance of the remaining probe sets
(Supplementary Information). This method is potentially applicable to other observational genome-wide
expression studies. In the subsequent significance analysis, sex indicator variables (taking values 0 or 1) were
included in the parametrization of the average time curve: µi(t) = αi + δi × sex + βTi s(t). This allows for
different intercepts for each sex.
Results
Experimental objectives and statistical formulations. We developed a general statistical
method that identifies genes showing temporal differential expression. This method was applied to
two human studies encompassing both types of temporal differential expression.
In one study, kidney samples were obtained from 72 human subjects ranging in age from 27
to 92 years. Only one array was obtained per sample and the age of the subject was recorded
(Materials and Methods). Figure 1a displays a simulated example of expression measured for this
type of study on a single probe set. The solid line is the population average time curve for the
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probe set, which is its true average expression over time with all sources of variation removed. The
points are the observed expression values, one per each individual, and these can be thought of as
independent random deviations from the solid line due to biological and measurement variation.
‘Independent sampling’ was performed in this study because each sample of cortex tissue represents
an independently sampled individual.
To determine whether each gene has expression that changes with age, our method involves
performing a hypothesis test on each gene of whether its population average time curve is flat
or not. We call this type of differential expression ‘within class temporal differential expression.’
Figure 1b shows the expression measurements from one of the genes in the study. (This is a highly
significant gene: CRABP1, a cellular retinoic acid binding protein.) The gene is tested by first
fitting a model under the null hypothesis that there is no differential expression, and then under
the alternative hypothesis that there is differential expression. The null model is the dashed flat
line, which minimizes the sum of squares among all possible flat lines. The alternative model is
the solid curve that minimizes the sum of squares among a general class of curves, namely natural
cubic splines. A statistic is calculated that compares the goodness of fit of these two models. This
statistic is a quantification of evidence for differential expression, and the larger it is the more
differentially expressed the gene appears to be. For every gene a statistic is calculated in this way,
and a significance cut-off is applied to them using a nonparametric false discovery rate criterion [15].
This process involves calculating the null distribution of the statistics when there is no differential
expression, which is accomplished through a data re-sampling technique.
In another study, eight human volunteers were randomly divided into endotoxin-treated and
control groups of equal size (Materials and Methods). Figure 2a is an artificial example of expression
measurements from a single gene in a group of four individuals. The solid line is the population
average time curve for this gene. The dashed lines are the average time curves for the individuals,
meaning that these are the true underlying time curves for each individual with the sources of
variation removed up to their individual variation. The deviation of an expression value from its
corresponding ‘individual average time curve’ can be thought of as an independent random event.
The deviation of an individual average time curve from the population average can also be thought
of as an independent random event. However, this implies that the deviations of expression values
from the population average time curve are correlated within individuals. The sampling performed
in this study is called ‘longitudinal sampling’ because each individual is observed at more than one
time point.
Here we want to identify genes that show significantly different expression between the endotoxin-
treated and control groups across time. We call this type of differential expression ‘between class
temporal differential expression.’ The methodology is applied similarly here as in the kidney study.
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Figure 1: (a) A simulated example of log-transformed expression measurements obtained by inde-
pendent sampling. The solid line is the population average time curve and the o’s are observed
expression values. (b) The log2-transformed expression values of the most significant gene in the
kidney aging study. The solid line is the curve fitted under the alternative hypothesis of differ-

































































































































Figure 2: (a) A simulated example of log-transformed expression measurements obtained from
longitudinal sampling of four individuals. The solid line is the population average time curve.
The dashed lines are the average time curves for the individuals. The points of a common shape
correspond to one of the individuals. (b) The log-transformed expression values of a significant gene
from the endotoxin study. The solid lines are the curves fitted under the alternative hypothesis of
differential expression. The dashed line is the curve fitted under the null hypothesis of no differential
expression.
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Figure 2b shows the expression measurements from one of the genes in the study. (This gene is
interferon regulatory factor 1, which is significant at a false discovery rate of 1%.) Under the null
hypothesis of no differential expression, the treated and control groups have the same population
average time curve. Therefore, a single curve (a natural cubic spline) is fit to the combined groups,
which is represented by the dashed curve in Figure 2b. The alternative model is formed by fitting
a separate curve to each group, as is shown by the solid lines in Figure 2b. A statistic is computed
based on the improvement in goodness of fit in going from a single curve to the separate curves for
each group. As before this statistic is a quantification of evidence for differential expression, and
the larger it is the more differentially expressed the gene appears to be. A significance cut-off is
applied to these statistics in the same fashion as in the kidney aging study.
In contrast to a static experiment, it is more difficult in the time course setting to form statistics
that accurately quantify differential expression. Determining the distribution of the statistics when
there is no differential expression is also more challenging. The behavior of expression over time may
vary greatly from gene to gene, so a flexible modeling approach must be taken in forming statistics.
Under certain study designs (e.g., the endotoxin study) there may be dependence between the
expression measurements within a single individual, which complicates the formation of statistics
and the simulation of the null distribution. Finally, simple permutation methods cannot be used
to simulate null statistics because of the complex structure of time course measurements.
Proposed statistical method. Methodology was developed to address these issues in a statisti-
cally rigorous fashion. In doing so, a general model for gene expression over time within a single
biological group was first carefully formulated. Even though a single model can be applied to both
studies (Supplementary Information), a simplified version is possible for the kidney study because
of its independent sampling scheme. Let yij be the relative expression level of gene i in individual
j, where there are i = 1, 2, . . . , 35068 probe sets and j = 1, 2, . . . , 72 individuals. Individual j
is observed at age tj , which lies somewhere between 27 and 92 years. The expression values are
modeled by
yij = µi(tj) + ²ij ,
where µi(tj) is the population average time curve for gene i evaluated at time tj , and ²ij is the
random deviation from this curve. In terms of Figure 1a, µi(t) is shown by the solid line. The
distance between this curve and an observed expression value is ²ij . The ²ij are assumed to be
independent random variables with mean zero and gene-dependent variance σ2i .
The following model was developed for the endotoxin study, and for longitudinal sampling in
general. Let yijk be the relative expression level of gene i on individual j at the kth time point,
where there are i = 1, 2, . . . , 44924 probe sets and j = 1, 2, . . . , 8 different individuals sampled (4
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within each group). For each individual, there were k = 1, 2, . . . , 6 time points observed at times
tjk, except for the one control who is missing two time points. The expression values are modeled
by
yijk = µi(tjk) + γij + ²ijk.
The population average time curve for gene i is again µi(t). Individual j deviates from µi(t) by γij ,
implying that µi(t) + γij is the individual average time curve for individual j. The measurement
error and remaining sources of random variation are modeled by ²ijk. In Figure 2a the solid line
is represented by µi(t), and the dashed lines by µi(t) + γij . Each expression value deviates from
its corresponding dashed line by ²ijk. The γij and ²ijk are assumed to be independent random
variables with means equal to zero and gene-dependent variances τ2i and σ
2
i , respectively. The case
where γij is modeled as a curve will be dealt with elsewhere; however, the endotoxin study did not
contain enough observations to permit this extra level of complexity.
The population average time curve µi(t) is parameterized in terms of an intercept plus a p-
dimensional linear basis:
µi(t) = αi + βTi s(t)
= αi + βi1s1(t) + βi2s2(t) + · · ·+ βipsp(t),
where s(t) = [s1(t), s2(t), . . . , sp(t)]T is a pre-specified p-dimensional basis, αi is the unknown gene-
specific intercept, and βi = [βi1, βi2, . . . , βip]T is a p-dimensional vector of unknown gene-specific
parameters. A common basis is defined by s1(t) = t, s2(t) = t2, . . . , sp(t) = tp [23]. That is, the
average curve µi(t) is modeled as a polynomial of degree p: µi(t) = αi + βi1t+ βi2t2 + · · ·+ βiptp.
The polynomial basis was effective in both studies, but a more flexible basis resulted in an increase
in power while making fewer assumptions. If the goal is to minimize the sum of squares from among
all continuous curves that are not ‘too curvy’, then there exists a unique solution called a natural
cubic spline, which can be parameterized by the B-spline basis [42]. Natural cubic spline models
have been developed and applied in a variety of other scenarios [25–33]. For either type of basis,
the curve was fit by minimizing the sum of squares between the curve and the observed expression
values, which reduces to fitting the αi and βi by standard least squares regression methods. The
model fitting procedure for longitudinal sampling is slightly more complicated in that it also takes
into account the dependence of measurements within an individual (Supplementary Information).
Not only does the basis representation of µi(t) facilitate model fitting, but it also greatly simpli-
fies the hypothesis tests for differential expression. They can now be written in terms of the αi and
βi for each gene, which is a source of flexibility in the types of designs that our method can consider.
Specifically, the tests do not depend on specific time points, so general sampling schemes may be
analyzed. In the kidney aging study, the null hypothesis of no differential expression is equivalent
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to restricting µi(t) to be a constant, and the alternative hypothesis of differential expression allows
µi(t) to be a curve. The null hypothesis model is fit under the constraint that µi(t) = αi and
βi = 0, and the alternative hypothesis model under the general parametrization of µi(t). For the
endotoxin study, the null hypothesis is that the treated and control groups have equal µi(t) (i.e.,
equal αi and βi), and the alternative hypothesis is that they are not equal. The null hypothesis
model is obtained by fitting a curve to the two groups combined, and the alternative hypothesis
model by fitting a separate curve to each group. In this particular study, we were not interested in a
difference in the intercepts αi because all individuals started out as untreated at time 0. Therefore
the intercept was implicitly assumed to be equal between the two groups under both hypotheses,
which comes down to a test for equality of the βi between the two groups. This will not always
be the case when testing for between class temporal differential expression, so we have developed
model fitting methods for both scenarios (Supplementary Information).
One of the difficulties in employing a basis representation of the time curves is that the dimension
p must be specified. This aspect is important because setting p too small may result in decreased
ability to capture the signal, while setting p too large wastes degrees of freedom. Either type of
error leads to a loss in power. We developed a method to automatically choose a single value of p
for all genes. The basic idea is to take a singular value decomposition of the expression data and
extract the top few ‘eigen-genes’, which are the eigen-vectors in the gene space [18]. The top eigen-
genes represent directions in the gene space that explain the most variance. Curves are fit to these
eigen-genes and p is chosen to be of sufficient size through a cross-validation technique. The method
chose p = 4 for both studies (although the fact that they are equal is a coincidence). In both cases,
this value yielded significance results that showed empirical evidence for being the most powerful
choice (Supplementary Information). Another option is to perform the significance analysis over a
range of p, although this could result in an anti-conservative bias. Also, when allowing p to vary
from gene to gene, a substantial inflation of significance was detected because p was chosen to work
well under the alternative hypothesis. One of the main motivations for specifying only one p for
all genes and using a singular value decomposition, which captures global trends in the data, was
to avoid over-fitting any particular gene.
A statistic for each gene was then formed that quantifies differential expression. The statistic
was defined to be an analogue of the t- and F-statistics that are commonly used in static differ-
ential expression methods. The statistic compares the goodness of fit of the model under the null
hypothesis to that under the alternative hypothesis. First, fitted values resulting from the null
and alternative models are calculated that correspond to each observed value. The residuals of the
model fits are then obtained by subtracting the fitted values from the observed values. Calculating










This is proportional to the typical F-statistic used in comparing two nested models. The intuition
behind the formula is that SS0i − SS1i quantifies the increase in goodness of fit, and dividing this
difference by SS1i provides exchangeability of the Fi across the genes. Justification and exact
formulas for all cases can be found in the Supplementary Information.
The null distribution of these statistics is calculated through a data re-sampling method called
the bootstrap [43]. The basic idea is that the data are re-sampled in such a way that new versions
of null data are randomly generated for each gene. More specifically, residuals from the alternative
model are first calculated. These residuals are randomly sampled with replacement and added back
to the null fitted values. Using these simulated null data, models are fit and statistics are formed
exactly as was done before to produce a set of null statistics. The re-sampling was performed on
each study for 500 bootstrap iterations. In the longitudinal sampling case, extra steps have to be
taken to deal with the dependence of residuals within an individual, but the basic idea is the same
(Supplementary Information).
The larger Fi is, the better the alternative model fit is over the null model fit. Therefore it is
reasonable to rank the genes for differential expression by the size of the Fi. This is equivalent to
calling genes significant that have Fi ≥ c for some positive cut-point c. It is straightforward to
form a p-value for each gene by calculating the frequency by which the null statistics exceed the
observed statistic. Even though the p-value is a useful measure of significance for an individual
gene, it is difficult to interpret a p-value threshold applied to thousands of genes simultaneously.
We instead estimated ‘q-values’ as the measure of significance for each gene.
The q-value is a false discovery rate (FDR) specific measure of significance. Estimation of q-
values in genomics studies, including for identifying differentially expressed genes, has previously
been proposed and studied [15, 44–46]. For a given significance threshold, the false discovery rate
is the proportion of false positives among all genes called significant:
FDR ≈ #false positive genes
#significant genes
.
The q-value of a particular gene measures the false discovery rate that is incurred when calling
that gene (and every gene more extreme) significant. For example, if a gene has a q-value of 1%,
then drawing the cut-off for significance at this gene leads to at most 1% false positives among
all significant genes. The observed statistics, null statistics, and significance rule were used to
estimate q-values for the genes as previously described (Supplementary Information). By applying
reasonable q-value cut-offs in both studies, many apparently relevant genes were called significant.
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Table 1: A comparison of the proposed method to a standard t-test and a “SAM” test (which
is a t-test with adaptive asymmetric thresholding). The ratio of the number of probe sets called
significant is an estimate of the increase in power that our procedure provides. For the static
methods, 8 subjects and 16 arrays were used to compared two time points (0h vs 2h and 0h vs
4h). The proposed method was compared to these in two ways. First, all 8 subjects and 46 arrays
were used, potentially giving our method an advantage due to a decrease in technical replication
variance. Second, only 4 subjects were used at times 0h, 4h, 6h, 24h for a total of 16 arrays, giving
the static methods a substantial advantage in that they have twice as many biological replicates.
The fairest comparison lies in between these two, even though both outperform the static methods
substantially.
Number of Probe Sets Called Significant
Q-value Proposed Method Proposed Method T-test SAM
Cut-off (8 subjects, 46 arrays) (4 subjects, 16 arrays) 0h vs 2h 0h vs 4h 0h vs 2h 0h vs 4h
1% 7409 548 0 0 0 0
2% 9188 2683 226 91 65 0
3% 10,467 4392 1678 837 1756 695
4% 11,642 5859 2524 1826 2535 1718
5% 12,720 7229 3202 2686 3101 2694
Analysis of systemic inflammatory response induced by LPS. In the endotoxin study there
are 4163, 7409, and 12720 significant probe sets at respective q-value cut-offs of 0.1%, 1%, and
5% (Supplementary Table 1). Figure 3A shows a hierarchical clustering [16] of the 4136 probe
sets significant at the 0.1% false discovery rate level. These results indicate that an endotoxin
injection causes a profound gene expression response in blood leukocytes, which is expected for a
number of reasons. First, in vivo administration of LPS invokes an acute systemic inflammation
which dramatically perturbs body’s physiology. Second, some differential expression may be due to
changing distributions of cell populations in the blood in addition to transcriptional changes [35].
Also, measuring differential expression over time is a more sensitive study design than the typical
static design; any change over time qualifies as differential expression. A t-test [15] and the SAM
software [9, 15] were used to test for differential expression between 0 and 2 hours, and between 0
and 4 hours. The significance results are displayed in Table 1, where it can be seen that an actual
time course analysis offers a sizeable increase in statistical power over a static design analysis.
To get a broad picture of the behavior of differentially expressed genes, a singular value de-
composition was performed on the 4163 most significant probe sets. Figure 4 shows the top two
eigen-genes that explain 66% and 16% of the variance, respectively. The relevant information is
13
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Figure 3: A. Hierarchical clustering of the probe sets found to be significant at a q-value cut-off of
0.1% in the endotoxin study. The columns are labeled according to group and time in hours. The
heat map is such that red intensity indicates high expression and blue intensity low expression B.
Functional analysis of genes. Shown are representative functions differentially enriched (difference
in log[significance] > 4) between the the groups of up-regulated (red) and down-regulated (blue)
genes. The significance values of these functions in the combined group are shown in gray.
14
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the shape of each eigen-gene, not their magnitudes or direction of differential expression. Among
the 4163 most significant probe sets 27% are up-regulated as the eigen-gene shows; 73% are down-
regulated, which is simply the reflection of the eigen-gene’s shape across the time axis. The second
eigen-gene shows more complex behavior, where changes in expression occur both directions over
the time course. Among these 4136 probe sets, 2914 unique genes (756 up, 2158 down)were identi-
fied from 3892 probe sets with mapped gene IDs (271 unmapped). Global functional analysis was
performed using gene ontology built from experimental evidence compiled in Ingenuity Pathways
Knowledge Base (IPKB) (Figure 3B and Supplementary Table 1).
The most significant functional groups from the 756 up-regulated genes take part in Immune
Response (121 genes), Inflammatory Disease (41 genes), Cellular Movement (84 genes), Tissue
Morphology (72 genes), and Cell Death (144 genes). These are consistent with an intense re-
sponse of leukocytes to LPS. The apparent expression of many elements of inflammation are up-
regulated, including secretive cytokines, chemokines and associated proteins (CCL20, CCL3, CCL4,
CXCL16, CXCL2, IL1A, IL1B, IL8, TNF, TNFSF13B, IL1RAP, IL1RN, TNFAIP3, TNFAIP6),
their membrane receptors (CCR1, IL10RB, IL18R1, IL18RAP, IL1R1, IL1R2, IL4R, IL8RA, IL9R,
TNFRSF6), toll-like receptors (TLR4, TLR5, TLR6, TLR8), Fc receptors (FCAR, FCER1G,
FCGR1A, FCGR2A, FCGR2B), interferon receptors (IFNGR1, IFNGR2, IFNAR1), protein tyro-
sine phosphatases (PTP4A1, PTPN2, PTPN22, PTPNS1, PTPRC, PTPRJ, PTPRN2, PTPRO),
JAK/STAT (JAK2, JAK3, STAT2, STAT3, STAT5A, STAT5B) and NFKB/IKB proteins (NFKB2,
NFKBIA, NFKBIE). These and other elevated genes participate in the activation of the extracel-
lular and intracellular signaling pathways in innate immune response, as well as many functions of
leukocytes, including cell movement of leukocytes, infiltration, migration, phagocytosis, activation,
chemotaxis, proliferation and recruitment. The most significantly up-regulated gene is ORM1, a
key acute phase plasma protein.
The most significantly down-regulated functions are Protein Synthesis (83 genes) including
genes of elongation initiation factors (EIF), ribosomal proteins (RPL/RPS), mitochondrial riboso-
mal protein (MRP); and RNA Post-Transcriptional Modification (60 genes), including genes such
as heterogeneous nuclear ribonucleoproteins (hnRNP), small nuclear ribonucleoproteins (SNRP),
splicing factors(SFRS). Members of RNA polymerase II (POLR2) are also decreased. Correspond-
ingly, genes involved in oxidative phosphorylation, such as mitochondrial complexes I (NDUF), II
(SDH), III (UQCR), and IV (COX) are also found to be significantly down-regulated. This con-
certed suppression of the cells protein syntheses, transcription programs and energy productions
may reflect a generalized stress response in blood leukocytes. Interestingly, expression of members
associated with the major histocompatibility complex class II (MHC II) complex is also suppressed
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Figure 4: The top two eigen-genes obtained from probe sets significant at a q-value cut-off of 0.1%
in the endotoxin study. The control individuals are represented by x’s and the treated individuals
by o’s. The dashed curve is the model fit to the control group and the solid curve is the model
fit to the treated group. (a) The first eigen-gene explains 66% of the variance. (b) The second
eigen-gene explains 16% of the variance.
16
Hosted by The Berkeley Electronic Press
sistent with the reduced antigen presenting capability after LPS shock.
Taking these results together, we observed a comprehensive transcriptional response to LPS
stimulation, where leukocyte cells reallocate resources and up-regulate transcription of genes in-
volved in innate immune and defense mechanisms.
Under the assumption that the control individuals have flat expression over time, it would have
sufficed to simply test the endotoxin individuals for within class temporal differential expression.
However, we found that among the controls at least 6% of the probe sets show within class temporal
differential expression (Supplementary Table 3). [The 6% estimate is directly obtained from the
false discovery rate procedure [15,44].] This indicates that the controls do in fact play an important
role in the analysis, which is not entirely surprising when considering that the study took place
over a 24 hour period where a number of potentially influential events may have taken place.
We also tested the endotoxin treated individuals for within class temporal differential expression
and found 5781, 16523, and 21789 significant probe sets at respective q-value cut-offs of 0.1%,
1%, and 5%. At the 1% and 5% q-value cut-offs there are over twice as many significant genes
compared to those obtained perviously. Given this and the fact that the controls do show within
class temporal differential expression, our conclusion is that it is necessary to use the treated and
controls individuals in a test for between class temporal differential expression in order to identify
genes differentially expressed due to LPS injection.
Analysis of age related genes in the kidney cortex. There appears to be substantial differ-
ential expression in this study, although not nearly as much as in the previous study. At q-value
cut-offs of 5% and 10%, there are 187 and 436 significant probe sets, respectively. The top eigen-
gene based on the 187 most significant probe sets shows a steady increase/decrease in expression,
and the second eigen-gene is flat (Supplementary Information). Among the 436 probe sets signif-
icant at 10%, 320 unique genes were identified from 389 probe sets with mapped gene IDs and 47
unmapped. Of these 320 genes, 240 have increased expression in kidneys of older age and 80 have
decreased expression.
Functional analysis was performed on these age-regulated genes (the complete information is
shown in Supplementary Table 2). The most significant functional group is Immune Response (69
genes), including genes such as associated with the complement component (C1QA, C1QB, C1QG,
C1QR1, C1R, C1S, C4A), cytokines, chemokines and receptors (CCL2, CCL20, CCR1, CX3CR1,
CXCL9, CXCR4, IL10RB, CSF1R, CSF2RB), and MHC II complex (FCER1G, HLA-DMA, HLA-
DPA1, HLA-DQB1, HLA-DRB1, HLA-DRB3). All but three of these genes show up-regulated
expression with age. This suggests an increased abundance of immune response genes in kidney
cortex, either as a result of low level of inflammation over life or as a compensation for the decreased
immune function in older age. Renal infiltration with immunocompetent cells which is known to
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correlate with renal diseases and increase over age can also account for some of these observed
changes.
The aging process has previously been shown to involve a widespread and complicated alterna-
tion in gene expression [36, 37, 47, 48]. In our analysis, significant genes were identified that have
a variety of cell-to-cell signaling and interaction (68 genes). For example, 34 genes are involved
in the quantity or mobilization of calcium and 14 genes in tyrosine phosphorylation. 59 genes
were identified as involved in apoptosis and cell death. The expression levels of apoptosis enhancer
proteins MYC (C-MYC), SP1 (Sp1 transcription factor), CASP1 (caspase1), UBD (ubiquitin D)
increase with age in the kidney, while the anti-apoptosis protein HSPA9B (mortalin-2) decreases
with age. However, the expression of BCL2A1, an inhibitor of the intrinsic apoptosis pathway, is
observed to be increasing with age [49].
Gene expression may change with age in response to declining kidney function and increased
susceptibility to kidney disease. Interestingly, a group of 12 genes known to be localized in mito-
chondrion (HSPA9B, COX8A, COX7C, AKAP1, BCKDHA, CLPP, FDX1, AMT, DBT, ATP5G3,
AK2, NME4) are identified as significant and their expression level uniformly declines in older age.
A number of age-regulated genes are also known to be involved in renal diseases, including C1QA,
CCR1, LYN, PTPRC, and TNFSF13B which all have positive correlation over age [50–54]. The
expression of TRPM6 (a transient receptor potential cation channel) negatively correlates with age,
and mutations of this gene cause hypomagnesemia with secondary hypocalcemia [55]. These genes
could therefore provide valuable information or as potential biomarkers on clinical course of kidney
aging.
We employed a 4-dimensional B-spline basis (p=4) in the significance analysis, although other
dimensions are possible. A 1-dimensional basis is equivalent to identifying differential expression by
fitting a linear regression and testing whether the slope is zero or not. Applied to log-transformed
expression data, a linear regression is only able to identify genes that show simple exponential be-
havior in their differential expression. By testing the null hypothesis of linear or flat log-transformed
expression, we found that at least 25% of the 35,068 probe sets are differentially expressed in a
manner more complex than an exponential function of age. Among the 417 most significant probe
sets in the kidney study, at least 93% of these are more complex than simple exponential behav-
ior. However, this may be a substantially exaggerated estimate due to the 417 probe sets being
preferentially sampled for nonlinear behavior. Thus, among the 417 most significant probe sets
when using the 1-dimensional basis, it is estimated that at least 47% of these are more complex
than simple exponential behavior. At a q-value cut-off of 5%, just over half of the genes found to
be significant using the 4-dimensional basis are also significant when using the 1-dimensional ba-
sis. Therefore, there is potentially a functional class of genes showing simple exponential temporal
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differential expression and another functional class showing substantially more complex differential
expression.
Discussion
We have proposed a significance method to identify differentially expressed genes in time course
microarray experiments and applied it to studies involving two types of sampling and both types of
temporal differential expression. The method may also be applied to more complicated situations,
where three or more groups are compared, for example. The four basic steps that are required for
a complete significance analysis method are included in the method: a statistic is formed for each
gene, the null distribution is calculated, the statistics are used to rank the genes, and a measure
of significance is applied to each gene that takes into account the multiple comparisons. There is
much detail that has been worked out to thoroughly and broadly define the method. Moreover, we
have attempted to justify the method in terms of well established statistical concepts. Extensive
simulations have been performed that test the robustness of the method under a variety of models
and sources of random variation. See the Supplementary Information for these details.
Temporally differentially expressed genes were identified in two time course microarray studies
on humans. The findings provide evidence that the method produces biologically meaningful results.
The human in vivo model of bacterial endotoxin represents a unique opportunity to examine the
onset of systemic inflammation in blood leukocytes. Our analysis suggests that a genome-wide
transcriptional response takes place where blood leukocytes reallocate resources and up-regulate
transcription of genes involved in innate immune and defense mechanisms, even though the response
to LPS is almost exclusively signaled by the toll-like receptor TLR4 pathway [56]. It was shown
that the inclusion of controls in this study played an important role, where the controls themselves
showed differential expression over time. In the clinical setting, comparing a treatment group to
“time 0” does not provide a proper control over the entire time course. The significance analysis
of the kidney aging study indicates that a large proportion of genes have expression that increases
with age, including those involved in signal transduction, cell growth, and genome stability. Genes
related to metabolism were found to be decreasing with age. We attempted to reduce the effect of
unobserved variables on our results, although this is not guaranteed to eliminate all confounders in
an observational study.
We have developed a freely available point-and-click software package called EDGE that in-





The Supplementary Information and Tables can be found at http://faculty.washington.edu/
jstorey/time/.
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